Published in Arterioscler Thromb Vasc Biol on June 01, 1999
Acid sphingomyelinase plays a key role in palmitic acid-amplified inflammatory signaling triggered by lipopolysaccharide at low concentrations in macrophages. Am J Physiol Endocrinol Metab (2013) 0.97
Borrelia burgdorferi organisms lacking plasmids 25 and 28-1 are internalized by human blood phagocytes at a rate identical to that of the wild-type strain. Infect Immun (2005) 0.80
Lipoprotein lipase gene is in linkage with blood pressure phenotypes in Chinese pedigrees. Hum Genet (2004) 0.77
Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment. Diabetes Care (1998) 1.59
Alterations of monocyte function in patients with growth hormone (GH) deficiency: effect of substitutive GH therapy. J Clin Endocrinol Metab (1999) 1.58
Specific interaction of Aspergillus fumigatus with fibrinogen and its role in cell adhesion. Infect Immun (1994) 1.22
In-vivo selection of an azole-resistant petite mutant of Candida glabrata. J Med Microbiol (2000) 1.19
Expression and identification of a laminin-binding protein in Aspergillus fumigatus conidia. Infect Immun (1997) 1.16
Direct regulatory effect of fatty acids on macrophage lipoprotein lipase: potential role of PPARs. Diabetes (2001) 1.02
Antiatherogenic properties of metformin: the experimental evidence. Diabetes Metab (2003) 0.99
Antineutrophil cytoplasmic autoantibodies: how should the biologist manage them? Clin Rev Allergy Immunol (2008) 0.98
Lymphopenia in occupational pulmonary silicosis with or without autoimmune disease. Clin Exp Immunol (2001) 0.95
Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants. J Leukoc Biol (2004) 0.91
Upregulation of macrophage lipoprotein lipase in patients with type 2 diabetes: role of peripheral factors. Diabetes (2000) 0.91
Silicon nephropathy and myeloperoxidase antibodies. Ann Rheum Dis (1994) 0.88
Prognosis of vasculitis associated myelodysplasia. Autoimmun Rev (2013) 0.87
Lack of concordance between plasma markers of cardiovascular risk and intima-media thickness in patients with type 2 diabetes. Diabetes Obes Metab (2004) 0.87
Anti-myeloperoxidase antibodies and associated diseases. Adv Exp Med Biol (1993) 0.84
[Dynamic study of anti-HIV antibody avidity after cellular immunity restoration under antiretroviral treatment]. Ann Biol Clin (Paris) (2001) 0.84
Immune restoration under HAART in patients chronically infected with HIV-1: diversity of T, B, and NK immune responses. Viral Immunol (2006) 0.83
Proliferative effect of lipoprotein lipase on human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2000) 0.83
[Palindromic rheumatism. Immunologic survey and study of development in 43 cases]. Rev Rhum Mal Osteoartic (1987) 0.82
Lipoprotein lipase enhances human monocyte adhesion to aortic endothelial cells. J Lipid Res (1997) 0.80
Effects of alloxan-induced diabetes on dopaminergic receptors in rat striatum and anterior pituitary. Horm Res (1985) 0.79
Differential regulation of macrophage peroxisome proliferator-activated receptor expression by glucose : role of peroxisome proliferator-activated receptors in lipoprotein lipase gene expression. Arterioscler Thromb Vasc Biol (2000) 0.79
Gliclazide decreases vascular smooth muscle cell dysfunction induced by cell-mediated oxidized low-density lipoprotein. Metabolism (2001) 0.78
Signalling pathways involved in retinal endothelial cell proliferation induced by advanced glycation end products: inhibitory effect of gliclazide. Diabetes Obes Metab (2004) 0.77
Stimulatory effect of glucose on macrophage lipoprotein lipase expression and production. Diabetes (1998) 0.77
[Serum and secretory immunoglobulins A. Molecular and cellular aspects of their biosynthesis and function]. Ann Med Interne (Paris) (1989) 0.77
Gliclazide reduces the induction of human monocyte adhesion to endothelial cells by glycated albumin. Diabetes Obes Metab (1999) 0.76
C-1-inhibitor binding monoclonal immunoglobins in three patients with acquired angioneurotic edema. J Allergy Clin Immunol (1996) 0.76
Gliclazide decreases cell-mediated low-density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial cells induced by oxidatively modified LDL. Metabolism (1997) 0.76
Anticentromere autoantibodies and Sicca syndrome. Br J Rheumatol (1994) 0.75
Non-coordinated biosynthesis of early complement components in a deficiency of complement proteins C1r and C1s. Scand J Immunol (1994) 0.75
Beneficial effects of gliclazide modified release compared with glibenclamide on endothelial activation and low-grade inflammation in patients with type 2 diabetes. Diabetes Obes Metab (2007) 0.75
[Bone densitometry by monochromatic photon absorption. Study of a normal population and values obtained in various pathological conditions]. Rev Rhum Mal Osteoartic (1985) 0.75
Dynamics of growth hormone responsiveness to growth hormone releasing factor in aging rats: peripheral and central influences. Neuroendocrinology (1991) 0.75
Determination of anti-neutrophil cytoplasm antibodies (ANCA) specificity by immunofluorescence on chronic myelocytic leukemia cells. J Immunol Methods (1992) 0.75
[Anti-cytoplasm antibodies of neutrophil polynuclear antibodies and associated diseases]. Ann Med Interne (Paris) (1991) 0.75
Association between acute lymphoblastic leukemia and partial IgA deficiency in a young man--a family study. Nouv Rev Fr Hematol (1990) 0.75
Intervention in diabetic vascular disease by modulation of growth factors. Metabolism (1995) 0.75
Isolation, purification and culture of Sertoli cells from immature piglet testes. Acta Endocrinol (Copenh) (1986) 0.75
[Detection of anti-neutrophil cytoplasmic antibodies with proteinase 3 specificity by immunoblotting]. Pathol Biol (Paris) (1994) 0.75
[Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis]. Ann Biol Clin (Paris) (2008) 0.75
Splenic lymphoma with circulating villous lymphocytes. Report of a case with immunologic and ultrastructural studies. Am J Clin Pathol (1992) 0.75
Blast crisis supervening on chronic lymphocytic leukaemia. A monoclonal progression of the disease as defined by cell surface markers. Eur J Haematol (1987) 0.75